- Home
- NMTC vs OFS Comparison
NMTC vs OFS Comparison
Compare NMTC & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMTC | OFS |
|---|---|---|
| Founded | 2009 | 2001 |
| Country | United States | United States |
| Employees | N/A | 47 |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.5M | 46.2M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | NMTC | OFS |
|---|---|---|
| Price | $0.73 | $4.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.98 | N/A |
| AVG Volume (30 Days) | 128.3K | ★ 137.5K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 17.89% |
| EPS Growth | ★ 80.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,097,692.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $31.90 | N/A |
| P/E Ratio | ★ N/A | $17.44 |
| Revenue Growth | ★ 163.47 | N/A |
| 52 Week Low | $0.50 | $2.72 |
| 52 Week High | $1.15 | $9.31 |
Technical Indicators
Market Signals| Indicator | NMTC | OFS |
|---|---|---|
| Relative Strength Index (RSI) | 46.20 | 63.11 |
| Support Level | $0.69 | $2.72 |
| Resistance Level | $0.75 | $4.44 |
| Average True Range (ATR) | 0.06 | 0.24 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 53.75 | 98.62 |
Price Performance
Historical ComparisonAbout NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to provide its stockholders with both current income and capital appreciation through debt investments and, to a lesser extent, equity investments.